Role of superficial femoral artery stents in the management of arterial occlusive disease: Review of current evidence

Vascular

Volumn 18, Issue 2, 2010, Pages 82-92

  Perrio, Stephen ^a   Holt, Peter J E ^a   Patterson, Benjamin O ^a   Hinchliffe, Robert J ^a   Loftus, Ian M ^a   Thompson, Matthew M ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Infrainguinal stent; Peripheral vascular disease; Superficial femoral artery angioplasty; Superficial femoral artery stent

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE SEQUENCE; EVIDENCE BASED PRACTICE; HUMAN; INTERMETHOD COMPARISON; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVIEW; STENT; SUPERFICIAL FEMORAL ARTERY; SYSTEMATIC REVIEW; VALIDITY; VASCULAR PATENCY;

AGED; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CONSTRICTION, PATHOLOGIC; EVIDENCE-BASED MEDICINE; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; RISK ASSESSMENT; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 77950845924     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2010.00009     Document Type: Review

References (30)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA2005 guidelines for the management of patients with peripheral arterial disease. J Am Coll Cardiol 2006;47:1239-1312
2. Watson K, Watson BD, Pater KS. Peripheral arterial disease: a review of disease awareness and management. Am J Geriatr Pharmacother 2006;4:365-379 (Pubitemid 46217445)
3. Baril DT, Marone LK, Kim J, et al. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions. J Vasc Surg 2008;48:627-633
4. Kandarpa K, Becker G, Ferguson R, et al. Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: part I. J Vasc Interv Radiol 2001;12:683-695 (Pubitemid 32521156)
5. Bosiers M, Deloose K, Verbist J, Peeters P. Present and future of endovascular SFA treatment: stents, stent-grafts, drug coated balloons and drug coated stents. J Cardiovasc Surg 2008;49:159-165 (Pubitemid 351833235)
6. Lampmann LEH. Stenting in the femoral superficial artery: an overview. Eur J Radiol 1999;29:276-279 (Pubitemid 29268383)
7. Laird JR, Zeller T, Gray BH, et al. Limb salvage following laser assisted angioplasty for critical limb ischaemia: results of the LACI multicentre trial. J Endovasc Ther 2006;13:1-11. (Pubitemid 43273492)
8. Franke J. Femoral Artery Stenting Trial - 12 month final analysis. A prospective, randomised, multi-centre trial to assess the efficacy of the self-expanding Bard Luminexx Nitinol-Stent vs balloon angioplasty in patients with superficial femoral artery disease. Herz 2007;32:69.
9. Van der Zaag ES, Legemate DA, Prins MH, et al. Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc 2004;28:132-137
10. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femeropoliteal stenting. J Am Coll Cardiol 2005;45:312-315 (Pubitemid 40094743)
11. Krankenberg H, Schlüter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial artery lesions up to 10cm in length: the Femoral Artery Stenting Trial (FAST). Circulation 2007;116:285-292 (Pubitemid 47196564)
12. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888 (Pubitemid 43872689)
13. Zdanowski Z, Albrechtsson U, Lundin A, et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? Int Angiol 1999;18:251-255
14. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomised trial. J Vasc Interv Radiol 2003;14:303-311
15. Becquemin JP, Favre JP, Marzelle J, et al. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg 2003;37:487-494 (Pubitemid 36350887)
16. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement infemoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001;12:23-31. (Pubitemid 32097991)
17. Vroegindeweij D, Vos LD, Tielbeek AV, et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997;20:420-425 (Pubitemid 27512031)
18. Surowiec SM, Davies MG, Eberly SW, et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2005;41:269-278 (Pubitemid 40342478)
19. Schmieder G, Richardson A, Scott E, et al. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes. J Vasc Surg 2008;48:1175-1181
20. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: The SIROCCO II trial. J Vasc Interv Radiol 2005;16:331-338 (Pubitemid 40354849)
21. Ferreira M, Lanziotti L, Monteiro M, et al. Superficial femoral artery recanalisation with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc 2007;34:702-708 (Pubitemid 350056379)
22. Abahji TN, Tató F, Rieger J, et al. Stenting of the superficial femoral artery after suboptimal balloon angioplasty: one-year results. Int Angiol 2006;25:184-189 (Pubitemid 44043716)
23. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997;25:74-83.
24. Vogel TR, Shindelman LE, Nackman GB, Graham AM. Efficacious use of nitinol stents in the femoral and popliteal arteries. J Vasc Surg 2003;38:1178-1184
25. Conroy RM, Gordon IL, Tobis JM, et al. Angioplasty and stent placement in chronic occlusion of the superficial femoral artery: technique and results. J Vasc Interv Radiol 2000;11:1009-1020
26. Cheng SW, Ting AC, Wong J. Endovascular stenting of superficial femoral artery stenosis and occlusions: results and risk factor analysis. Cardiovasc Surg 2001;9:133-140 (Pubitemid 32206162)
27. Ihnat DM, Duong ST, Taylor ZT. Contemporary outcomes after superficial artery angioplasty and stenting: the influence of TASC classification and runoff score. J Vasc Surg 2008;47:967-974
28. Sabeti S, Schillinger M, Amighi J, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score adjusted analysis. Radiology 2004;232:516-521 (Pubitemid 38971294)
29. Lenti M, Cieri E, De Rango P, et al. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent. J Vasc Surg 2007;45:32-39 (Pubitemid 46038649)
30. Greenberg D, Rosenfield K, Garcia LA, et al. In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial). J Vasc Interv Radiol 2004;15:1065-1069 (Pubitemid 39346686)